The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status
Diabetes, Obesity and Metabolism · 2025-07 · 27 (7) · 3967-3983
DOI: 10.1111/dom.16433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 02.05.2025. Verfasst von Weijie Zhai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Body Mass Index, Obesity, Cognitive Dysfunction, Apolipoproteins E. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jilin Provincial Department of Finance, Natural Science Foundation of Jilin Province, the General Program of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
To explore the relationship between body mass index (BMI) and its changes in relation to cognitive decline across different cognitive status, while also examining the role of the APOE genotype in these associations. Materials and Methods A total of 23 255 individuals from the National Alzheimer's Coordinating Center (NACC) were analysed using multivariable logistic and Cox regression to assess BMI and its variability in relation to cognitive decline. Subgroup analyses were conducted to explore how APOE genotype interacts with BMI and cognitive decline.
Results
Compared to individuals with normal cognition and normal BMI, being underweight was associated with a higher risk of developing MCI (HR 3.065, 95% CI: [1.156–8.126]) and dementia (HR 4.057, 95% CI: [1.433–11.483]). Over the 4.07‐year follow‐up, 9171 individuals experienced cognitive decline. Longitudinal analysis revealed that being overweight or obese was linked to a lower risk of cognitive decline across different cognitive status, including impaired not MCI, MCI and dementia, but had no effect on those with normal cognition. Additionally, compared to stable BMI, the hazard ratios (95% CI) for developing dementia were 2.336 (2.128–2.565) and 2.338 (2.119–2.581) for annual BMI gain or loss greater than 5%. However, different APOE genotypes may influence the effect of BMI and BMI variability on cognitive decline.
Conclusions
This research supports the ‘obesity paradox’ and highlights the critical role of APOE in modulating BMI's influence on cognitive health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Jilin University, Changchun, China.
- Cognitive Center, Department of Neurology, The First Hospital of Jilin University, Jilin University, Changchun, China.
ORCID-Profile: Weijie Zhai, Li Sun
Förderung
- Jilin Provincial Department of Finance
- Natural Science Foundation of Jilin Province
- the General Program of the National Natural Science Foundation of China
- STI2030-Major Projects
- Department of Finance of Jilin Province
Zitieren
APA
Zhai, W., Zhang, G., Wei, C., Zhao, M., & Sun, L. (2025). The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status. Diabetes, Obesity and Metabolism, 27(7), 3967-3983. https://doi.org/10.1111/dom.16433
Vancouver
Zhai W, Zhang G, Wei C, Zhao M, Sun L. The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status. Diabetes, Obesity and Metabolism. 2025;27(7):3967-3983. doi:10.1111/dom.16433
BibTeX
@article{Zhai2025,
author = {Zhai, Weijie and Zhang, Guimei and Wei, Chunxiao and Zhao, Meng and Sun, Li},
title = {The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {7},
pages = {3967--3983},
doi = {10.1111/dom.16433}
}
EUVIMED